These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 29550204)

  • 1. A Texture Analysis-Based Prediction Model for Lymph Node Metastasis in Stage IA Lung Adenocarcinoma.
    Gu Y; She Y; Xie D; Dai C; Ren Y; Fan Z; Zhu H; Sun X; Xie H; Jiang G; Chen C
    Ann Thorac Surg; 2018 Jul; 106(1):214-220. PubMed ID: 29550204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prediction model for N2 disease in T1 non-small cell lung cancer.
    Zhang Y; Sun Y; Xiang J; Zhang Y; Hu H; Chen H
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1360-4. PubMed ID: 22819364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicoradiographic Predictors of Aggressive Biology in Lung Cancer With Ground Glass Components.
    Nelson DB; Godoy MCB; Benveniste MF; Shewale JB; Spicer JD; Mitchell KG; Hofstetter WL; Mehran RJ; Rice DC; Sepesi B; Walsh GL; Vaporciyan AA; Swisher SG; Roth JA; Antonoff MB
    Ann Thorac Surg; 2018 Jul; 106(1):235-241. PubMed ID: 29534957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of pathological nodal involvement by CT-based Radiomic features of the primary tumor in patients with clinically node-negative peripheral lung adenocarcinomas.
    Liu Y; Kim J; Balagurunathan Y; Hawkins S; Stringfield O; Schabath MB; Li Q; Qu F; Liu S; Garcia AL; Ye Z; Gillies RJ
    Med Phys; 2018 Jun; 45(6):2518-2526. PubMed ID: 29624702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histogram analysis of computed tomography numbers of clinical T1 N0 M0 lung adenocarcinoma, with special reference to lymph node metastasis and tumor invasiveness.
    Nomori H; Ohtsuka T; Naruke T; Suemasu K
    J Thorac Cardiovasc Surg; 2003 Nov; 126(5):1584-9. PubMed ID: 14666037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifying invasiveness of clinical stage IA lung adenocarcinoma with computed tomography texture features.
    Qiu ZB; Zhang C; Chu XP; Cai FY; Yang XN; Wu YL; Zhong WZ
    J Thorac Cardiovasc Surg; 2022 Mar; 163(3):805-815.e3. PubMed ID: 33541730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors for lymph node metastasis in clinical stage IA lung adenocarcinoma.
    Ye B; Cheng M; Li W; Ge XX; Geng JF; Feng J; Yang Y; Hu DZ
    Ann Thorac Surg; 2014 Jul; 98(1):217-23. PubMed ID: 24841547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictability and Utility of Contrast-Enhanced CT on Occult Lymph Node Metastasis for Patients with Clinical Stage IA-IIA Lung Adenocarcinoma: A Double-Center Study.
    Zhao F; Zhao Y; Zhang Y; Sun H; Ye Z; Zhou G
    Acad Radiol; 2023 Dec; 30(12):2870-2879. PubMed ID: 37003873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1365-71. PubMed ID: 22883546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for lymph node metastasis and surgical methods in patients with early-stage peripheral lung adenocarcinoma presenting as ground glass opacity.
    Wang Y; Jing L; Wang G
    J Cardiothorac Surg; 2020 Aug; 15(1):121. PubMed ID: 32782020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes and predictive factors for pathological node-positive in radiographically pure-solid, small-sized lung adenocarcinoma.
    Kayata H; Isaka M; Terada Y; Mizuno K; Yasuura Y; Kojima H; Ohde Y
    Gen Thorac Cardiovasc Surg; 2019 Jun; 67(6):544-550. PubMed ID: 30627979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery].
    Wang X; Zheng L; Zhang SY; Xie ZM; Yu H; Su XD; Wang JY; Huang ZF; Yang MT; Rong TH
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):456-9. PubMed ID: 19950559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
    Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors that predict lymph node status in clinical stage T1aN0M0 lung adenocarcinomas.
    Ye B; Cheng M; Ge XX; Geng JF; Li W; Feng J; Hu DZ; Zhao H
    World J Surg Oncol; 2014 Feb; 12():42. PubMed ID: 24559138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification predicts occult lymph node metastasis in clinically mediastinal node-negative lung adenocarcinoma.
    Yeh YC; Kadota K; Nitadori J; Sima CS; Rizk NP; Jones DR; Travis WD; Adusumilli PS
    Eur J Cardiothorac Surg; 2016 Jan; 49(1):e9-e15. PubMed ID: 26377636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological characteristics and lymph node metastasis pathway of non-small-cell lung cancer located in the left lingular division.
    Shien K; Toyooka S; Soh J; Okami J; Higashiyama M; Kadota Y; Maeda H; Hayama M; Chida M; Funaki S; Okumura M; Miyoshi S
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):791-6. PubMed ID: 25805399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of three measurements on computed tomography for the prediction of less invasiveness in patients with clinical stage I non-small cell lung cancer.
    Matsuguma H; Oki I; Nakahara R; Suzuki H; Kasai T; Kamiyama Y; Igarashi S; Mori K; Endo S; Yokoi K
    Ann Thorac Surg; 2013 Jun; 95(6):1878-84. PubMed ID: 23618519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Predictors of Nodal Metastases in Peripherally Clinical T1a N0 Non-Small Cell Lung Cancer.
    Ghaly G; Rahouma M; Kamel MK; Nasar A; Harrison S; Nguyen AB; Port J; Stiles BM; Altorki NK; Lee PC
    Ann Thorac Surg; 2017 Oct; 104(4):1153-1158. PubMed ID: 28551047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of lymphatic invasion in the prognosis of patients with clinical node-negative and pathologic node-positive lung adenocarcinoma.
    Mimae T; Tsutani Y; Miyata Y; Yoshiya T; Ibuki Y; Kushitani K; Takeshima Y; Nakayama H; Okumura S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2014 Jun; 147(6):1820-6. PubMed ID: 24507979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a clinical prediction model for N2 lymph node metastasis in non-small cell lung cancer.
    Chen K; Yang F; Jiang G; Li J; Wang J
    Ann Thorac Surg; 2013 Nov; 96(5):1761-8. PubMed ID: 23998401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.